Clinical trial
Study of External Beam Radiation Therapy With and Without Hormonal Therapy to…
NCT00116220 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00116220 |
|---|---|
| Title | Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer |
| Official title | A Phase III Trial of External Beam of Radiotherapy +/- Total Androgen Suppression for High Risk Clinically Organ-Confined Prostate Cancer |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Saint Anne's Hospital Beth Israel Deaconess Medical Center Metro West Medical Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Flutamide (Eulexin) and Lupron or Zoladex, External Beam Radiotherapy |
| Enrollment | 206 |
| Start date | Sep 1, 1995 |
| Primary completion | Apr 1, 2001 |
| Completion | Feb 1, 2015 |
| First posted | Jun 28, 2005 |
| Last update posted | Jan 6, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: